Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-05-25 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIRAZEIL (47200), Lot-et-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE VIRAZEIL : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE VIRAZEIL is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIRAZEIL (47200),
this company of category PME
shows in 2025 a net income positive of 45 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE VIRAZEIL (SIREN 840975411)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
45 130 €
74 764 €
84 244 €
109 317 €
77 572 €
76 605 €
-18 112 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
En 2025, SELARL PHARMACIE DE VIRAZEIL genera un resultado neto positivo de 45 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 130 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 183%. Situación crítica: la deuda supera significativamente los fondos propios. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 31%. El equilibrio entre fondos propios y deuda es satisfactorio.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
182.694%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
30.977%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE VIRAZEIL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1371.322
826.909
542.86
365.728
276.801
217.547
182.694
Financial autonomy
6.12
9.643
13.719
18.634
23.315
27.723
30.977
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Ratio de endeudamiento
182.692025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
En 2025, el ratio de endeudamiento de SELARL PHARMACIE DE VIRAZEIL (182.69) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.
Autonomía financiera
30.98%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
En 2025, el autonomía financiera de SELARL PHARMACIE DE VIRAZEIL (31.0%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.
Liquidity ratios
El ratio de liquidez se sitúa en 124.41. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
124.407
Liquidity indicators evolution SELARL PHARMACIE DE VIRAZEIL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
223.935
271.99
192.035
179.414
174.544
157.703
124.407
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Ratio de liquidez
124.412025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Vigilar-19 pts over 3 years
En 2025, el ratio de liquidez de SELARL PHARMACIE DE VIRAZEIL (124.41) se sitúa en el 25% más bajo del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio inferior a 1 puede señalar tensiones potenciales de flujo de caja.
Positioning of SELARL PHARMACIE DE VIRAZEIL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE VIRAZEIL is estimated at
716 895 €
(range 486 488€ - 1 124 907€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
486k€716k€1124k€
716 895 €Range: 486 488€ - 1 124 907€
NAF 5 année 2025
Valuation method used
Net Income Multiple
45 130 €
×
15.9x
=716 895 €
Range: 486 489€ - 1 124 908€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE VIRAZEIL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE VIRAZEIL
What is the revenue of SELARL PHARMACIE DE VIRAZEIL ?
The revenue of SELARL PHARMACIE DE VIRAZEIL is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DE VIRAZEIL profitable?
Yes, SELARL PHARMACIE DE VIRAZEIL generated a net profit of 45 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE VIRAZEIL ?
The headquarters of SELARL PHARMACIE DE VIRAZEIL is located in VIRAZEIL (47200), in the department Lot-et-Garonne.
Where to find the tax return of SELARL PHARMACIE DE VIRAZEIL ?
The tax return of SELARL PHARMACIE DE VIRAZEIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE VIRAZEIL operate?
SELARL PHARMACIE DE VIRAZEIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart